CLOV vs IPSC
Clover Health Investments Corp (CLOV) versus Century Therapeutics Inc (IPSC) — a side-by-side from cached financials, not a winner call.
Clover Health Investments Corp (CLOV) is a healthcare plans company listed on US.
Century Therapeutics Inc (IPSC) is a biotechnology company listed on US.
Latest reported CLOV revenue for 2024-12-31 was $1.37B. Net income was -$43.0M. Revenue was up 8.8% from 2023-12-31 to 2024-12-31. CLOV currently screens at market cap $1.55B.
Latest reported IPSC revenue for 2024-12-31 was $6.6M. Net income was -$126.6M. Revenue was up 194.8% from 2023-12-31 to 2024-12-31. IPSC currently screens at market cap $47.8M.
CLOV currently screens at market cap $1.55B. IPSC currently screens at market cap $47.8M.
Not investment advice. Open the CLOV and IPSC stock pages for the full models.
Not investment advice.